Saturday, October 8, 2016

BurnEze Spray





1. Name Of The Medicinal Product



BurnEze Spray.


2. Qualitative And Quantitative Composition



Benzocaine Ph Eur 1.0% w/w.



3. Pharmaceutical Form



Aerosol spray.



4. Clinical Particulars



4.1 Therapeutic Indications



For the symptomatic relief of pain from minor superficial burns and scalds where the skin is unbroken.



4.2 Posology And Method Of Administration



For topical administration. Adults, the elderly, and children: To reduce pain and blistering, use BurnEze Spray as quickly as possible. Hold nozzle five inches from the skin and spray once for 2-3 seconds. Stop spraying immediately if a white frost deposit (frost) appears. If necessary, the application may be repeated once only after 15 minutes. If pain persists seek medical advice.



4.3 Contraindications



Do not use if you are sensitive to benzocaine.



4.4 Special Warnings And Precautions For Use



Patients with any known allergy should seek medical advice. Do not apply to large areas or to broken skin. Do not use in or near the mouth or eyes or under conditions in which significant inhalation is likely. Avoid freezing the skin by repeated or prolonged use. Seek medical advice immediately if burns are extensive (particularly in young children or if they affect fingers, toes or sensitive areas). For external use only. Keep out of the reach of children. Flammable. Do not use near fire or flame. Pressurised container. Protect from sunlight and do not expose to temperatures exceeding 50oC. Do not pierce or burn, even after use. Do not spray on a naked flame or any incandescent material. Do not use near or place container on polished or painted surfaces.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None known.



4.6 Pregnancy And Lactation



Safety of use in pregnancy and lactation has not been established.



4.7 Effects On Ability To Drive And Use Machines



None known.



4.8 Undesirable Effects



May cause allergic dermatitis in sensitive individuals.



4.9 Overdose



An overdose is extremely unlikely with this type of preparation.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



The active ingredient, benzocaine, is a local anaesthetic which relieves pain. The physical effects of the cooling propellants help reduce pain and blistering.



5.2 Pharmacokinetic Properties



BurnEze Spray is applied topically to the affected area.



5.3 Preclinical Safety Data



Not applicable.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Ethanol, Denatured; Isobutane; N-pentane.



6.2 Incompatibilities



None known.



6.3 Shelf Life



Three years.



6.4 Special Precautions For Storage



Do not store above 25oC.



6.5 Nature And Contents Of Container



Aluminium cans (60ml) internally coated with epoxyphenolic lacquer fitted with valve assembly and actuator button, protected by a plastic cap.



6.6 Special Precautions For Disposal And Other Handling



None.



7. Marketing Authorisation Holder



Seton Products Limited, Tubiton House, Oldham, OL1 3HS.



8. Marketing Authorisation Number(S)



PL 11314/0038.



9. Date Of First Authorisation/Renewal Of The Authorisation



15th December 1994 / 13th March 2000./ 16/09/2005



10. Date Of Revision Of The Text



16/09/2005





No comments:

Post a Comment